Home
Home Home
       
Im
Back to Anglo Platinum  | Downloads  | Glossary  | Contact  
Home
Im
       Home
   
     Profile & mission
   
     Key features
   
     Chairman‘s statement
   
     The board & executive
   
     CEOs‘ review
   
     Finance review
   
  +   Market review
   
  +   Operations review
   
     Ore reserves & mineral resources review
   
     Projects review
   
  +   Company statistics
   
       Financial statements
Approval of the Annual Financial Statements
Declaration by the Company Secretary
Auditor‘s Report
Directors‘ Report
Remuneration Report
Audit Committee Report
Principal accounting policies
Consolidated Income Statement
Segmental Information
Consolidated Balance Sheet
Consolidated Cash Flow Statement
Group Statement of Recognised Income and Expense
United States Dollar Equivalent Consolidated Income Statement
United States Dollar Equivalent Consolidated Balance Sheet
United States Dollar Equivalent Consolidated Cash Flow Statement
Notes to the Consolidated Financial Statements
Annexures
Appendix 1
   
  +   Directorate &
management
   
  +   Shareholders‘
information
   
Financial statements  |  Notes to the Consolidated Financial Statements
print   print page email   email page download   PDF 639KB
Im
 
   
Notes to the Consolidated Financial Statements
31. Employee benefits (continued)
Retirement funds
Separate funds, independent of the Group, provide retirement and other benefits to all employees. These funds consist of defined contribution plans and a defined benefit plan. All funds are subject to the Pension Funds Act, 1956. The Amplats Officials Pension Fund is in the process of being wound up, whereupon the administration of pensioners will be outsourced and active members will be transferred to an appropriate retirement fund. 
Defined contribution plans
Contributions are made to the following defined contribution plans:
    Number of
members*
Number of
pensioners
Employer
contributions
Rm
Market value
of fund assets
Rm
2007
Amplats Retirement Fund 1,250 47 611
Amplats Mines Retirement Fund 13,301 220 2,582
MRR Retirement Fund 1,083 23 505
Amplats Group Provident Fund 38,812 266 2,711
Amplats Officials Pension Fund 13 2,736 — * 210
    54,459 2,736 556 6,619
2006
Amplats Retirement Fund 1,259 40 540
Amplats Mines Retirement Fund 11,579 189 2,351
MRR Retirement Fund 1,102 22 474
Amplats Group Provident Fund 32,374 221 2,382
Amplats Officials Pension Fund 16 2,741 —* 196
    46,330 2,741 472 5,943
  * Certain members are not in the employment of the Group, while others are members of more than one fund
Defined benefit plan
Post-retirement medical aid benefits
The post-retirement medical aid obligation is actuarially valued annually. The obligation was last valued as at
31 December 2007 using the projected unit credit method. The assumptions used in the valuation included estimates of life expectancy and long-term estimates of the increase in medical costs, appropriate discount rates and the level of claims based on the Group's experiences.

The plan assets comprise a captive cell arrangement with Guardrisk, which arrangement exists to fund the Group's obligations towards pensioners. The funds are invested in the money market and the medical aid premiums are paid by Guardrisk to the medical aid funds on behalf of the Group. The Group expects to make a contribution of R12,959,100 (2007: R12,705,000) to the captive cell for the 2008 year. The actual return on plan assets for the year amounted R5,639,904 (2006: R4,941,971). 
        2007 2006
The principal actuarial assumptions used were as follows:    
Actuarial assumptions
Discount rate (nominal) 8.0% 8.3%
Healthcare cost inflation 6.3% 6.3%
Expected return on reimbursive rights 9.0% 9.3%
Membership
In-service members 314 337
  Continuation members     1,072 1,185
   
 
 
  Page up  
  Page  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75    

Previous page  |  Financial statements 44/75
 
   
  Home
  Disclaimer  
Home  
 
Valid HTML 4.01 Transitional